Influence of atrial natriuretic peptide treatment on cardiovascular and renal nitric oxide system in spontaneously hypertensive rats.

COSTA MARÍA DE LOS ÁNGELES; RODRIGUEZ IERASE DANIELA; ELESGARAY ROSANA; VISINTINI JAIME MARIA FLORENCIA; CANIFFI CAROLINA; BALASZCZUK ANA MARÍA; ARRANZ CRISTINA

Buenos Aires

Congreso; World Congress of Cardiology 2008; 2008

World Heart Federation

<!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1610611985 1073750139 0 0 159 0;} @font-face {font-family:Verdana; panose-1:2 11 6 4 3 5 4 4 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:536871559 0 0 0 415 0;} @font-face {font-family:"Arial!important"; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-alt:"Times New Roman"; mso-font-charset:0; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:0 0 0 0 0 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoPapDefault {mso-style-type:export-only; margin-bottom:10.0pt; line-height:115%;} @page WordSection1 {size:612.0pt 792.0pt; margin:72.0pt 72.0pt 72.0pt 72.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> Introduction: We have previously demonstrated that nitric oxide (NO) system mediates atrial natriuretic peptide (ANP) hypotensive, natriuretic and diuretic effects in normotensive rats. We also showed that ANP would stimulate NO synthase (NOS) activity interacting with natriuretic peptides receptors NPR-A/B, increasing cGMP, and/or NPR-C, coupled via G protein, which activates Ca2+-calmodulin dependent NOS. Objective: The aim of the present study was to investigate the effects of chronic ANP infusion on systolic blood pressure (SBP) and cardiovascular and renal NO system in spontaneously hypertensive rats (SHR). Methods: 16-weeks old SHR and normotensive Wistar-Kyoto rats (WKY) were infused subcutaneously (osmotic pumps) with saline (NaCl 0.9%) or ANP (100 ng/hour.rat), during seven days. SBP was recorded and nitrites and nitrates excretion (NOx, metabolic end products of NO) were determined during the experimental time. At the end of this period, the animals were sacrificed by decapitation and NOS activity (using [14C] L-arginine as substrate) were determined in aorta artery (A), right atria (RA), left ventricle (LV) and renal medulla (M) and cortex (C). Results: Chronic infusion of ANP diminished SBP (WKY= -13±3 vs SHR= -25 ± 10 mmHg, ns) and increased NOx (WKY = 41 ± 10 % vs SHR = 23 ± 4 %, p